162 related articles for article (PubMed ID: 18665212)
1. Demonstration of a novel HIV-1 restriction phenotype from a human T cell line.
Han Y; Wang X; Dang Y; Zheng YH
PLoS One; 2008 Jul; 3(7):e2796. PubMed ID: 18665212
[TBL] [Abstract][Full Text] [Related]
2. A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.
Zhou T; Han Y; Dang Y; Wang X; Zheng YH
Retrovirology; 2009 Apr; 6():31. PubMed ID: 19344514
[TBL] [Abstract][Full Text] [Related]
3. Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.
Zhou T; Dang Y; Baker JJ; Zhou J; Zheng YH
Retrovirology; 2012 Nov; 9():93. PubMed ID: 23134572
[TBL] [Abstract][Full Text] [Related]
4. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
Han Y; Wang X; Dang Y; Zheng YH
PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
[TBL] [Abstract][Full Text] [Related]
6. Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z; Yu Z; Wang L; Zheng Y; Yao X
PLoS One; 2008 Apr; 3(4):e1995. PubMed ID: 18414671
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathway.
Zhou T; Dang Y; Zheng YH
J Virol; 2014 Mar; 88(6):3474-84. PubMed ID: 24403586
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
9. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
Ochsenbauer C; Wilk T; Bosch V
J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414
[TBL] [Abstract][Full Text] [Related]
10. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.
Bouyac M; Rey F; Nascimbeni M; Courcoul M; Sire J; Blanc D; Clavel F; Vigne R; Spire B
J Virol; 1997 Mar; 71(3):2473-7. PubMed ID: 9032385
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
Sheehy AM; Gaddis NC; Choi JD; Malim MH
Nature; 2002 Aug; 418(6898):646-50. PubMed ID: 12167863
[TBL] [Abstract][Full Text] [Related]
12. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.
Madani N; Kabat D
J Virol; 1998 Dec; 72(12):10251-5. PubMed ID: 9811770
[TBL] [Abstract][Full Text] [Related]
13. T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner.
Vallanti G; Lupo R; Federico M; Mavilio F; Bovolenta C
Mol Ther; 2005 Oct; 12(4):697-706. PubMed ID: 16039909
[TBL] [Abstract][Full Text] [Related]
14. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
Simm M; Pekarskaya O; Potash MJ; Volsky DJ
AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
[TBL] [Abstract][Full Text] [Related]
15. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.
Wiegand HL; Doehle BP; Bogerd HP; Cullen BR
EMBO J; 2004 Jun; 23(12):2451-8. PubMed ID: 15152192
[TBL] [Abstract][Full Text] [Related]
16. Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.
Goffinet C; Schmidt S; Kern C; Oberbremer L; Keppler OT
J Virol; 2010 Nov; 84(21):11374-84. PubMed ID: 20702620
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
Marin M; Rose KM; Kozak SL; Kabat D
Nat Med; 2003 Nov; 9(11):1398-403. PubMed ID: 14528301
[TBL] [Abstract][Full Text] [Related]
18. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
Gabuzda DH; Lawrence K; Langhoff E; Terwilliger E; Dorfman T; Haseltine WA; Sodroski J
J Virol; 1992 Nov; 66(11):6489-95. PubMed ID: 1357189
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
[TBL] [Abstract][Full Text] [Related]
20. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
Mariani R; Chen D; Schröfelbauer B; Navarro F; König R; Bollman B; Münk C; Nymark-McMahon H; Landau NR
Cell; 2003 Jul; 114(1):21-31. PubMed ID: 12859895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
